|1.||Stepura, O B: 3 articles (05/2009 - 01/2000)|
|2.||Martynov, A I: 2 articles (01/2015 - 01/2000)|
|3.||Martynow, A I: 2 articles (05/2009 - 01/2009)|
|4.||Gromova, O A: 1 article (01/2015)|
|5.||Kalacheva, A G: 1 article (01/2015)|
|6.||Torshin, I Iu: 1 article (01/2015)|
|7.||Oshchepkova, E V: 1 article (01/2015)|
|8.||Maksimov, N I: 1 article (01/2013)|
|9.||Gaĭsin, I R: 1 article (01/2013)|
|10.||Shilina, L V: 1 article (01/2013)|
|1.||Mitral Valve Prolapse
01/01/2005 - "According to results of clinical and instrumental investigation magnesium orotate (50 mg/day during first week and 25 mg/day thereafter) was found to be effective therapy of children with syndrome of cardiac connective tissue dysplasia (mainly with mitral valve prolapse and anomalous chordae tendineae)."
|2.||Male Infertility (Male Sterility)
05/01/2009 - "Aim of this study was to evaluate adjuvant magnesium orotate on mortality and clinical symptoms in patients with severe heart failure under optimal cardiovascular medication. "
01/09/2009 - "Aim of this study was to evaluate adjuvant magnesium orotate on mortality and clinical symptoms in patients with severe heart failure under optimal cardiovascular medication. "
05/01/2009 - "Magnesium orotate may be used as adjuvant therapy in patients on optimal treatment for severe congestive heart failure, increasing survival rate and improving clinical symptoms and patient's quality of life."
05/01/2009 - "In a monocentric, controlled, double-blind study, 79 patients with severe congestive heart failure (NYHA IV) under optimal medical cardiovascular treatment were randomised to receive either magnesium orotate (6000 mg for 1 month, 3000 mg for about 11 months, n = 40) or placebo (n = 39). "
05/01/2009 - "Magnesium orotate in severe congestive heart failure (MACH)."
01/31/1970 - "[Arteriosclerosis, myocardial infarct and blood lipids, their therapeutic modification by magnesium orotate]."
09/01/1998 - "At the Hamburg symposium on magnesium orotate, a number of studies of this form of metabolic supplementation were presented that indicate orotic acid and its magnesium salt have a modest beneficial effect on the myocardium under conditions of stress ranging from myocardial infarction to severe physical exercise. "
|2.||Thioctic Acid (Lipoic Acid)
|3.||Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
|8.||Inosine Monophosphate (IMP)
|9.||gluconic acid (gluconate)